Cargando…

On the origin of myeloid-derived suppressor cells

Myeloid-derived suppressor cells (MDSCs) have a strong immunosuppressive character that allows them to regulate immune responses and hinder overt inflammatory responses. In cancer, this leads to tumor immune evasion and disease progression. MDSCs come in at least two forms: monocytic (Mo-MDSCs) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Millrud, Camilla Rydberg, Bergenfelz, Caroline, Leandersson, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356220/
https://www.ncbi.nlm.nih.gov/pubmed/27690299
http://dx.doi.org/10.18632/oncotarget.12278
_version_ 1782515778496495616
author Millrud, Camilla Rydberg
Bergenfelz, Caroline
Leandersson, Karin
author_facet Millrud, Camilla Rydberg
Bergenfelz, Caroline
Leandersson, Karin
author_sort Millrud, Camilla Rydberg
collection PubMed
description Myeloid-derived suppressor cells (MDSCs) have a strong immunosuppressive character that allows them to regulate immune responses and hinder overt inflammatory responses. In cancer, this leads to tumor immune evasion and disease progression. MDSCs come in at least two forms: monocytic (Mo-MDSCs) and granulocytic (G-MDSCs). The classical definition of MDSCs as immature myeloid cells blocked from differentiating has been challenged by recent studies suggesting that Mo-MDSCs and G-MDSCs may represent monocytes and granulocytes that have acquired immunosuppressive properties. The molecular mechanism behind their generation and their true origins are now widely debated. In this review we discuss the different proposed mechanisms of the generation of both types of MDSCs, with a special focus on human MDSCs in cancer.
format Online
Article
Text
id pubmed-5356220
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53562202017-04-20 On the origin of myeloid-derived suppressor cells Millrud, Camilla Rydberg Bergenfelz, Caroline Leandersson, Karin Oncotarget Review Myeloid-derived suppressor cells (MDSCs) have a strong immunosuppressive character that allows them to regulate immune responses and hinder overt inflammatory responses. In cancer, this leads to tumor immune evasion and disease progression. MDSCs come in at least two forms: monocytic (Mo-MDSCs) and granulocytic (G-MDSCs). The classical definition of MDSCs as immature myeloid cells blocked from differentiating has been challenged by recent studies suggesting that Mo-MDSCs and G-MDSCs may represent monocytes and granulocytes that have acquired immunosuppressive properties. The molecular mechanism behind their generation and their true origins are now widely debated. In this review we discuss the different proposed mechanisms of the generation of both types of MDSCs, with a special focus on human MDSCs in cancer. Impact Journals LLC 2016-09-27 /pmc/articles/PMC5356220/ /pubmed/27690299 http://dx.doi.org/10.18632/oncotarget.12278 Text en Copyright: © 2017 Millrud et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Millrud, Camilla Rydberg
Bergenfelz, Caroline
Leandersson, Karin
On the origin of myeloid-derived suppressor cells
title On the origin of myeloid-derived suppressor cells
title_full On the origin of myeloid-derived suppressor cells
title_fullStr On the origin of myeloid-derived suppressor cells
title_full_unstemmed On the origin of myeloid-derived suppressor cells
title_short On the origin of myeloid-derived suppressor cells
title_sort on the origin of myeloid-derived suppressor cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356220/
https://www.ncbi.nlm.nih.gov/pubmed/27690299
http://dx.doi.org/10.18632/oncotarget.12278
work_keys_str_mv AT millrudcamillarydberg ontheoriginofmyeloidderivedsuppressorcells
AT bergenfelzcaroline ontheoriginofmyeloidderivedsuppressorcells
AT leanderssonkarin ontheoriginofmyeloidderivedsuppressorcells